EP About this file: EP0761208

EP0761208 - Process for preparing dry pharmaceutical forms and compositions thus made [Right-click to bookmark this link]
Status	The application has been refused Status updated on 04.10.2002 Database last updated on 05.04.2025
Most recent event Tooltip	05.10.2005	Change: Appeal number
Applicant(s)	For all designated states Laboratoires EFFIK Eurospace 7, Route de Gisy 91571 Bievres Cédex / FR
	[1997/11]
Inventor(s)	01 / Duclos, Roselyne 7, Rue du Nid de Chien FR-76240 Bonsecours / FR
	02 / Terracol, Didier 4, Allée des Lauriers FR-91370 Verrieres le Buisson / FR
	[1997/11]
Representative(s)	Dossmann, Gérard, et al Casalonga & Partners Bayerstrasse 71-73 80335 München / DE
	[N/P]
Former [1999/16]	Dossmann, Gérard, et al Bureau D.A. Casalonga-Josse Morassistrasse 8 80469 München / DE
Former [1997/11]	Burtin, Jean-François Cabinet GEFIB 85 Rue Anatole France 92300 Levallois Perret / FR
Application number, filing date	96401602.6	18.07.1996
	[1997/11]
Priority number, date	WO1995FR01009	27.07.1995 Original published format: PCT/FR95/01009
	[1997/11]
Filing language	FR
Procedural language	FR
Publication	Type:	A1 Application with search report
	No.:	EP0761208
	Date:	12.03.1997
	Language:	FR
	[1997/11]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	10.01.1997
Classification	IPC:	A61K9/14	[1997/11]
	CPC:	A61K9/146 (EP,US); A61K9/145 (EP,US)
Designated contracting states	AT, BE, CH, DE, DK, ES, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1997/11]
Title	German:	Verfahren zur Herstellung trockener Arzneiformen sowie die auf diese Weise erhaltenen Zusammensetzungen	[1997/11]
	English:	Process for preparing dry pharmaceutical forms and compositions thus made	[1997/11]
	French:	Procédé de préparation de formes pharmaceutiques sèches et les compositions ainsi réalisées	[1997/11]
Examination procedure	29.08.1997	Examination requested [1997/44]
	16.06.1999	Despatch of a communication from the examining division (Time limit: M06)
	23.12.1999	Reply to a communication from the examining division
	10.02.2000	Despatch of a communication from the examining division (Time limit: M04)
	10.03.2000	Reply to a communication from the examining division
	15.11.2000	Despatch of communication of intention to grant (Approval: No)
	30.03.2001	Despatch of a communication from the examining division (Time limit: M02)
	06.06.2001	Reply to a communication from the examining division
	06.11.2001	Despatch of communication that the application is refused, reason: substantive examination [2002/47]
	29.09.2002	Application refused, date of legal effect [2002/47]
Appeal following examination	08.01.2002	Appeal received No. T0514/02
	16.09.2002	Result of appeal procedure: appeal of the applicant inadmissible
Fees paid	Renewal fee
	27.07.1998	Renewal fee patent year 03
	23.07.1999	Renewal fee patent year 04
	26.05.2000	Renewal fee patent year 05
	29.06.2001	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	31.07.2002	07 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]JPS6438029 ;
		[A]BE385316 (PRODUITS ROCHE) [A] 7 * the whole document *;
		[A]DE1053736 (KONINK NL GIST & SPIRITUSFABRI) [A] 7 * column 3; example 5 *;
		[X]DE2822882 (YAMANOUCHI PHARMA CO LTD) [X] 1-13 * page 7, paragraph 3 * * page 13; examples 4,5 * * page 14; example 7 *;
		[X]EP0012523 (AMERICAN HOME PROD [US]) [X] 1-3,5,7-13 * page 15, line 15 - line 16 *;
		[X]LU84468 (ELAN CORP LTD [IE]) [X] 1-4,6-8,14 * the whole document * * page 5, line 8 *;
		[Y]EP0371471 (BANYU PHARMA CO LTD [JP]) [Y] 25,26 * page 2, line 1 - line 6 * * page 3, line 10 - page 4, line 5 ** page 7; example 4 *;
		[XY] - S.M. SAFWAT ET AL., "PREFORMULATION of progesterone dosage forms. release characteristics and bioavailability of progesterone suppositories", CHEMICAL ABSTRACTS, (19920629), vol. 116, no. 26, Database accession no. 262375k, page 449, column 1, XP002021829 [X] 1,3,4,6-8,14-16 * abstract * [Y] 25,26
		[ ] - PHARM. IND., vol. 53, no. 12, pages 1144 - 1150
		[X] - DATABASE WPI, 1, Derwent World Patents Index, vol. 12, no. 89, Database accession no. 89-088668, XP002021830 & JPS6438029 A 19890208 (TAKADA K) [X] 1,3-14,24 * abstract *
	by applicant	- W.L. CHIOU, S. RIEGELMAN, J. PHARM. SCI., (1971), vol. 60, pages 1281 - 1302
		- J.L. FORD, PHARM. ACTA. HELV., (1986), vol. 61, no. 3, pages 69 - 88
		- D.W. BLOCH, P.P. SPEISER, PHARM. ACTA. HELV., (1987), vol. 62, no. 1, pages 23 - 27
		- C.I. CHIOU, S. RIEGELMAN, "Pharmaceutical applications of solid dispersion systems", J. PHARM. SCI., (1971), vol. 60, no. 9, pages 1281 - 1302
		- D. DUCHENE, "Les dispersions solides. Stabilite et conservation", STP PHARMA, (1985), vol. 1, no. 11, pages 1064 - 1073
		- D. DUCHENE, "Les dispersions solides; interet et limites", LES ENTRETIENS DU CARLA, (1986), vol. VII, pages 99 - 107
		- J.L. FORD, "The current status of solid dispersions", PHARM. ACTA. HELV., (1986), vol. 6, no. 3, pages 69 - 88
		- F. PUISIEUX, S. HENRY, LABO. PHARMA PROB. ET TECH., (1981), vol. 305, pages 11 - 20
		- K. SEKIGUCHI, N. OBI, "Studies on absorption of eutectic mixtures. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man.", CHEM. PHARM. BULL., (1961), vol. 9, pages 866 - 872

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 35p